Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

International variation in medication prescription rates among elderly patients with inflammatory bowel disease.

Benchimol EI, Cook SF, Erichsen R, Long MD, Bernstein CN, Wong J, Carroll CF, Frøslev T, Sampson T, Kappelman MD.

J Crohns Colitis. 2013 Dec;7(11):878-89. doi: 10.1016/j.crohns.2012.09.001. Epub 2012 Sep 25.

PMID:
23018106
4.

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.

van Staa TP, Card T, Logan RF, Leufkens HG.

Gut. 2005 Nov;54(11):1573-8. Epub 2005 Jun 30. Review.

5.

A national survey on the patterns of treatment of inflammatory bowel disease in Canada.

Hilsden RJ, Verhoef MJ, Best A, Pocobelli G.

BMC Gastroenterol. 2003 Jun 5;3:10.

6.

Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.

Bokemeyer B, Hardt J, Hüppe D, Prenzler A, Conrad S, Düffelmeyer M, Hartmann P, Hoffstadt M, Klugmann T, Schmidt C, Weismüller J, Mittendorf T, Raspe H.

J Crohns Colitis. 2013 Jun;7(5):355-68. doi: 10.1016/j.crohns.2012.02.014. Epub 2012 Apr 12.

PMID:
22503168
7.

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.

Mitra D, Hodgkins P, Yen L, Davis KL, Cohen RD.

BMC Gastroenterol. 2012 Sep 24;12:132. doi: 10.1186/1471-230X-12-132.

8.

Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study.

Damas OM, Jahann DA, Reznik R, McCauley JL, Tamariz L, Deshpande AR, Abreu MT, Sussman DA.

Am J Gastroenterol. 2013 Feb;108(2):231-9. doi: 10.1038/ajg.2012.393. Epub 2012 Dec 18.

PMID:
23247580
9.

Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.

Metge CJ, Blanchard JF, Peterson S, Bernstein CN.

Am J Gastroenterol. 2001 Dec;96(12):3348-55.

PMID:
11774948
10.

A United Kingdom inflammatory bowel disease database: making the effort worthwhile.

Bardhan KD, Simmonds N, Royston C, Dhar A, Edwards CM; Rotherham IBD Database Users Group..

J Crohns Colitis. 2010 Oct;4(4):405-12. doi: 10.1016/j.crohns.2010.01.003. Epub 2010 Feb 19.

PMID:
21122536
11.

Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada.

Benchimol EI, Guttmann A, Mack DR, Nguyen GC, Marshall JK, Gregor JC, Wong J, Forster AJ, Manuel DG.

J Clin Epidemiol. 2014 Aug;67(8):887-96. doi: 10.1016/j.jclinepi.2014.02.019. Epub 2014 Apr 26.

PMID:
24774473
12.

Health Care utilization in elderly onset inflammatory bowel disease: a population-based study.

Nguyen GC, Sheng L, Benchimol EI.

Inflamm Bowel Dis. 2015 Apr;21(4):777-82. doi: 10.1097/MIB.0000000000000306.

PMID:
25738376
13.

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.

Dig Liver Dis. 2005 Jun;37(6):407-17. Review.

PMID:
15893279
14.

Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region.

Stepaniuk P, Bernstein CN, Nugent Z, Singh H.

Can J Gastroenterol Hepatol. 2015 Jun-Jul;29(5):274-8. Epub 2015 Apr 15.

15.

Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.

Abraham NS, Richardson P, Castillo D, Kane SV.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1281-7. doi: 10.1016/j.cgh.2013.06.004. Epub 2013 Jun 19.

PMID:
23792295
16.

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Burisch J, Pedersen N, Čuković-Čavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group..

Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.

PMID:
23604131
17.

Current therapy of inflammatory bowel disease in children.

Rufo PA, Bousvaros A.

Paediatr Drugs. 2006;8(5):279-302. Review.

PMID:
17037946
18.

Methotrexate for maintenance of remission in ulcerative colitis.

Wang Y, MacDonald JK, Vandermeer B, Griffiths AM, El-Matary W.

Cochrane Database Syst Rev. 2015 Aug 11;(8):CD007560. doi: 10.1002/14651858.CD007560.pub3. Review.

PMID:
26263042
19.

Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China.

Zhai H, Liu A, Huang W, Liu X, Feng S, Wu J, Yao Y, Wang C, Li Q, Hao Q, Hu J, Zhang S.

BMC Gastroenterol. 2016 Jan 12;16:2. doi: 10.1186/s12876-015-0405-0.

20.

Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.

Vijverman A, Piront P, Belaiche J, Louis E.

Acta Gastroenterol Belg. 2006 Jan-Mar;69(1):1-4.

PMID:
16673554

Supplemental Content

Support Center